ArticleJournal of managed care & specialty pharmacy2018

Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products.

Bartholomew J Tortella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.